| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Fiscal 2024 Outlook Increased
The Company increased guidance for fiscal 2024 as follows:
|
(as of February 5, 2024) |
Updated Fiscal 2024 Guidance |
Previous Guidance |
|
Net Sales: |
$175 million to $185 million |
$170 million to $180 million |
|
Gross Margin: |
Approx. 20% of sales |
18% to 19% of sales |
|
SG&A expense(1) |
16% to 17% of sales |
15% to 16% of sales |
|
Adjusted EBITDA(2) |
$15.0 million to $16.0 million |
$11.5 million to $13.5 million |
|
Effective Tax Rate |
22% to 23% |
22% to 23% |
|
CapEx |
$8.0 million to $10.0 million |
$12.0 million to $13.5 million |
Posted In: GHM
